[Alaskan] Clinic Puts New HIV Test on Trial

Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

[Alaskan] Clinic Puts New HIV Test on Trial

Anchorage Daily News (www.adn.com) (12/06/00) P. 2B
Potempa, Ann

OraSure Technologies' OraQuick HIV test is being tested in Planned Parenthood clinics in Anchorage and Soldotna, Alaska, joining other testing sites around the United States and in Africa. For taking the rapid test, participants will receive $20; however, they will not be given results because the test has not yet received Food and Drug Administration (FDA) approval. Participants will be interviewed, and then receive an oral swab, a finger prick, and have a blood sample taken. The OraQuick test will analyze the first two samples, while the blood sample will be tested with an approved HIV screen. OraSure spokesman Richard George explained that the company did not want to highlight test results in the study because it wanted to include a variety of people in its research, not just people who think they are infected. Anna Franks, executive director of Alaska's Planned Parenthood, noted that if people are concerned they are infected, they should be screened with an FDA-approved test.
001207
AD002183

Copyright © 2000 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.